Daclatasvir Daklinza
Elbasvir-Grazoprevir Zepatier
Glecaprevir-Pibrentasvir Mavyret
Ledipasvir-Sofosbuvir Harvoni
Ombitasvir-Paritaprevir-Ritonavir Technivie
Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir Viekira Pak
Peginterferon alfa-2a Pegasys
Peginterferon alfa-2b PegIntron
Ribavirin Copegus, Rebetol, Ribasphere
Simeprevir Olysio
Sofosbuvir Sovaldi
Sofosbuvir-Velpatasvir Epclusa
Sofosbuvir-Velpatasvir-Voxilaprevir VoseviModule 4. Evaluation and Preparation for Hepatitis C Treatment
Lesson 1. Goals for Treatment and Predicting Response
Section Navigation
Section Navigation
- Module 4 Overview
Evaluation and Preparation for Hepatitis C Treatment - 0%Lesson 1
Goals for Treatment and Predicting ResponseActivities- 1A.Core Concepts
- 1B.Goals for Treatment and Predicting Response
- 1C.ACG Treatment Resources
- Lesson 1 Quiz/CME/CNE
- 0%Lesson 2
Making a Decision on When to Initiate HCV TherapyActivities- 2A.Core Concepts
- 2B.Making a Decision on Whether to Initiate Treatment
- 2C.Impact of Successful Treatment of Hepatitis C
- Lesson 2 Quiz/CME/CNE
- 0%Lesson 3
Cost and Access to Direct-Acting Antiviral AgentsActivities- 0%Lesson 4
Evaluating Persons with Substance or Alcohol Use Prior to Treatment of Hepatitis CLesson 1. Goals for Treatment and Predicting Response
Learning Objective Performance Indicators
- Discuss the goals and rationale for hepatitis C therapy with patients considering treatment.
- Predict a patient's response to treatment for chronic hepatitis C infection based on specific host and viral factors.
CNE/CME Continuing Education
This lesson qualifies for 1 CME AMA PRA Category 1 Credit™ or 1 CNE contact hour. View CE Notices.Steps to Acquire CE for this Activity:
2Give Feedback
Complete survey3Print Certificate
Obtain proof of CEInstructions
To complete this lesson you must work through all Lesson 1 Activities (listed below and on the left-hand navigation bar). After finishing the lesson activities, take the Lesson 1 Quiz. You can choose to obtain Continuing Medical Education (CME) or Continuing Nursing Education (CNE) credit at that point, but you must answer at least 80% of the questions correctly. After finishing the Lesson 1 Quiz, proceed to the next Lesson. After finishing all Module 4 lessons, you will be ready to take the Module 4 Self-Assessment.About this Lesson
Learning Objective Performance Indicators
- Discuss the goals and rationale for hepatitis C therapy with patients considering treatment.
- Predict a patient's response to treatment for chronic hepatitis C infection based on specific host and viral factors.
CNE/CME Continuing Education
This lesson qualifies for 1 CME AMA PRA Category 1 Credit™ or 1 CNE contact hour. View CE Notices.Steps to Acquire CE for this Activity:
2Give Feedback
Complete survey3Print Certificate
Obtain proof of CEInstructions
To complete this lesson you must work through all Lesson 1 Activities (listed below and on the left-hand navigation bar). After finishing the lesson activities, take the Lesson 1 Quiz. You can choose to obtain Continuing Medical Education (CME) or Continuing Nursing Education (CNE) credit at that point, but you must answer at least 80% of the questions correctly. After finishing the Lesson 1 Quiz, proceed to the next Lesson. After finishing all Module 4 lessons, you will be ready to take the Module 4 Self-Assessment.Share by e-mail
Check
-On-
Learning
QuestionsThe Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your undestanding of key concepts.You must be signed in to customize your interaction with these questions.
Funded by a grant from the Centers for Disease Control and Prevention
- HCV Medications
- Daclatasvir (Daklinza)
- Elbasvir-Grazoprevir (Zepatier)
- Glecaprevir-Pibrentasvir (Mavyret)
- Ledipasvir-Sofosbuvir (Harvoni)
- Ombitasvir-Paritaprevir-Ritonavir (Technivie)
- Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir (Viekira Pak)
- Peginterferon alfa-2a (Pegasys)
- Peginterferon alfa-2b (PegIntron)
- Ribavirin (Copegus, Rebetol, Ribasphere)
- Simeprevir (Olysio)
- Sofosbuvir (Sovaldi)
- Sofosbuvir-Velpatasvir (Epclusa)
- Sofosbuvir-Velpatasvir-Voxilaprevir (Vosevi)
- Course Modules
- Screening and Diagnosis of Hepatitis C Infection
- Evaluation, Staging, and Monitoring of Chronic Hepatitis C
- Management of Cirrhosis-Related Complications
- Evaluation and Preparation for Hepatitis C Treatment
- Treatment of Chronic Hepatitis C Infection
- Treatment of Special Populations and Special Situations
- Special Topics
- Slide LecturesCore ConceptsMaster Bibliography
ContributorsSite OverviewContent Bundles - Clinical Calculators
Copyright © 2017 Hepatitis C Online - AWS
Contact Us | Terms and Conditions | Privacy Policy
CE (CNE/CME) Notices | Copyright and Attribution Notices
Hepatitis C Online
CE (CNE/CME) Notices | Copyright and Attribution Notices
Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: 2.4.3-a